{"id":70,"date":"2024-06-21T15:11:00","date_gmt":"2024-06-21T13:11:00","guid":{"rendered":"http:\/\/aplusa.local\/?p=70"},"modified":"2026-02-03T17:12:51","modified_gmt":"2026-02-03T16:12:51","slug":"social-media-impact-of-asco-2024","status":"publish","type":"post","link":"https:\/\/www.aplusaresearch.com\/fr\/perspectives\/social-media-impact-of-asco-2024\/","title":{"rendered":"Impact de l'ASCO 2024 sur les m\u00e9dias sociaux"},"content":{"rendered":"<p>La r\u00e9union annuelle de l'ASCO 2024 s'est d\u00e9roul\u00e9e du 31 mai au 4 juin 2024 \u00e0 Chicago, Il, \u00c9tats-Unis. Cette ann\u00e9e, l'\u00e9v\u00e9nement s'est principalement d\u00e9roul\u00e9 en personne, avec des diffusions virtuelles disponibles. Comme c'est le cas depuis 2019, nous \u00e9valuerons l'impact de la conf\u00e9rence en ligne :<\/p>\n\n\n\n<p><strong>Du point de vue des HCP :<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Conditions et m\u00e9dicaments les plus discut\u00e9s pendant la p\u00e9riode d'\u00e9coute<\/li>\n\n\n\n<li>Les messages des professionnels de la sant\u00e9 qui ont suscit\u00e9 le plus d'engagement<\/li>\n\n\n\n<li>Essais cliniques les plus mentionn\u00e9s par les professionnels de la sant\u00e9<\/li>\n\n\n\n<li>Focus sur le my\u00e9lome multiple et les tests mol\u00e9culaires<\/li>\n<\/ul>\n\n\n\n<p><br><strong>Du point de vue des entreprises pharmaceutiques :<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Principales entreprises pharmaceutiques (en termes de mentions)<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Champ d'application<\/h2>\n\n\n\n<p>L'analyse porte sur les mentions provenant du monde entier*.<\/p>\n\n\n\n<p>Un total de 107K mentions a \u00e9t\u00e9 enregistr\u00e9 pendant la p\u00e9riode d'\u00e9coute du 24 mai 2024 au 11 juin 2024 (une semaine avant et apr\u00e8s la conf\u00e9rence).<\/p>\n\n\n\n<p>Toutes les mentions proviennent de X (anciennement connu sous le nom de Twitter).<\/p>\n\n\n\n<p>Au total, 12 000 auteurs uniques ont \u00e9t\u00e9 identifi\u00e9s.<\/p>\n\n\n\n<p class=\"is-style-text-annotation\">*#asco24 OR #asco2024 OR (asco NEAR\/2 (2024 OR 24))<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">M\u00e9thodologie<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"960\" height=\"284\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/methodoly.webp\" class=\"wp-image-288\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/methodoly.webp 960w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/methodoly-300x89.webp 300w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/methodoly-768x227.webp 768w\" sizes=\"auto, (max-width: 960px) 100vw, 960px\" \/><\/figure>\n\n\n\n<p class=\"is-style-text-annotation\">**#asco24 OR #asco2024 OR (asco NEAR\/2 (2024 OR 24))<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Volume des conversations<\/h2>\n\n\n\n<p>Il y a eu une forte diminution 31 32% augmentation des mentions globales par rapport \u00e0 ASCO 2023. Parmi les types d'utilisateurs class\u00e9s dans ce suivi de congr\u00e8s, les HCP repr\u00e9sentent la majeure partie des conversations avec 74%.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"960\" height=\"401\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/volume-of-conv.webp\" class=\"wp-image-290\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/volume-of-conv.webp 960w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/volume-of-conv-300x125.webp 300w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/volume-of-conv-768x321.webp 768w\" sizes=\"auto, (max-width: 960px) 100vw, 960px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Top posts (de HCP)<\/h2>\n\n\n\n<p>Le plus appr\u00e9ci\u00e9 : Cet article, publi\u00e9 avant la conf\u00e9rence, anticipe les r\u00e9sultats d'\u00e9tudes sur le cancer thoracique avec une mention sp\u00e9ciale pour l'essai LAURA ainsi qu'un algorithme d\u00e9taill\u00e9 de l'\u00e9tat actuel du traitement du cancer du poumon.<\/p>\n\n\n\n<p>Le plus grand nombre de rediffusions : Ce post a mis en \u00e9vidence l'essai clinique ESOPEC qui a montr\u00e9 une prolongation de la survie globale avec le r\u00e9gime de chimioth\u00e9rapie p\u00e9riop\u00e9ratoire FLOT dans l'ad\u00e9nocarcinome de l'\u0153sophage.<\/p>\n\n\n\n<p>Le plus grand nombre de r\u00e9ponses : Les messages ayant re\u00e7u le plus de commentaires \u00e9taient des messages de f\u00e9licitations \u00e0 l'\u00e9gard du Dr Manochakian qui a re\u00e7u le titre de FASCO.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"620\" height=\"418\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/most-engagement.webp\" class=\"wp-image-291\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/most-engagement.webp 620w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/most-engagement-300x202.webp 300w\" sizes=\"auto, (max-width: 620px) 100vw, 620px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Cancers et mol\u00e9cules les plus cit\u00e9s (d'apr\u00e8s le HCPS)<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"1256\" height=\"544\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/top-mentioned-cancers-molecules.webp\" class=\"wp-image-292\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/top-mentioned-cancers-molecules.webp 1256w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/top-mentioned-cancers-molecules-300x130.webp 300w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/top-mentioned-cancers-molecules-1024x444.webp 1024w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/top-mentioned-cancers-molecules-768x333.webp 768w\" sizes=\"auto, (max-width: 1256px) 100vw, 1256px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">SOV des essais cliniques les plus discut\u00e9s (# de mentions) : le cancer du poumon domine<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"1373\" height=\"552\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/sov-of-clinical-trials-most-discussed.webp\" class=\"wp-image-293\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/sov-of-clinical-trials-most-discussed.webp 1373w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/sov-of-clinical-trials-most-discussed-300x121.webp 300w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/sov-of-clinical-trials-most-discussed-1024x412.webp 1024w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/sov-of-clinical-trials-most-discussed-768x309.webp 768w\" sizes=\"auto, (max-width: 1373px) 100vw, 1373px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Focus sur le my\u00e9lome multiple<\/h2>\n\n\n\n<p>Cette ann\u00e9e, la conf\u00e9rence de l'ASCO \u00e9tait fortement ax\u00e9e sur les anticorps monoclonaux et plus particuli\u00e8rement sur le daratumumab et le conjugu\u00e9 anticorps-m\u00e9dicament \u00e9tudi\u00e9s dans les essais DREAMM-7 et 8.<\/p>\n\n\n\n<p>L'essai clinique IMROZ, le plus mentionn\u00e9, qui a montr\u00e9 une am\u00e9lioration de la PFS et de la OS avec la quadrith\u00e9rapie Isa-Vrd par rapport \u00e0 Vrd seul chez les patients NDMM in\u00e9ligibles \u00e0 la transplantation, a \u00e9t\u00e9 bien accueilli par les HCP.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Sujets de discussion (type de traitement)<\/h3>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"455\" height=\"199\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/topics-of-discussion.webp\" class=\"wp-image-294\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/topics-of-discussion.webp 455w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/topics-of-discussion-300x131.webp 300w\" sizes=\"auto, (max-width: 455px) 100vw, 455px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"461\" height=\"236\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/nuage-de-mots-1.webp\" class=\"wp-image-295\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/nuage-de-mots-1.webp 461w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/nuage-de-mots-1-300x154.webp 300w\" sizes=\"auto, (max-width: 461px) 100vw, 461px\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\">Volume des mentions<\/h3>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"424\" height=\"85\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/volume-of-mentions.webp\" class=\"wp-image-296\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/volume-of-mentions.webp 424w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/volume-of-mentions-300x60.webp 300w\" sizes=\"auto, (max-width: 424px) 100vw, 424px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Essais cliniques les plus mentionn\u00e9s<\/h3>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"554\" height=\"201\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/most-mentioned-clinical-trial-1.webp\" class=\"wp-image-297\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/most-mentioned-clinical-trial-1.webp 554w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/most-mentioned-clinical-trial-1-300x109.webp 300w\" sizes=\"auto, (max-width: 554px) 100vw, 554px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Mol\u00e9cules les plus cit\u00e9es<\/h3>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"517\" height=\"129\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/most-mentioned-molecules.webp\" class=\"wp-image-298\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/most-mentioned-molecules.webp 517w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/most-mentioned-molecules-300x75.webp 300w\" sizes=\"auto, (max-width: 517px) 100vw, 517px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Principaux messages des professionnels de la sant\u00e9 par engagement<\/h3>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"341\" height=\"415\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/post-2-3.webp\" class=\"wp-image-299\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/post-2-3.webp 341w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/post-2-3-247x300.webp 247w\" sizes=\"auto, (max-width: 341px) 100vw, 341px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">L'accent mis sur les tests mol\u00e9culaires<\/h2>\n\n\n\n<p>KIM-1 a \u00e9t\u00e9 mis en \u00e9vidence comme un nouveau biomarqueur pronostique et pr\u00e9dictif potentiel pour les patients atteints de cancer du col de l'ut\u00e9rus en phase adjuvante. <a href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03024996\" data-type=\"link\" data-id=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03024996\" target=\"_blank\" rel=\"noreferrer noopener\">IMmotion-010<\/a> est l'essai associ\u00e9. Ce d\u00e9veloppement a suscit\u00e9 un int\u00e9r\u00eat consid\u00e9rable de la part des professionnels de la sant\u00e9 en ligne.<\/p>\n\n\n\n<p>CLEAR a \u00e9t\u00e9 l'essai le plus mentionn\u00e9. Il a montr\u00e9 que les signatures g\u00e9nomiques n'aidaient pas \u00e0 s\u00e9lectionner la th\u00e9rapie pour les patients atteints de cancer du col de l'ut\u00e9rus selon les HCP en ligne.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Sujets de discussion (biomarqueurs les plus mentionn\u00e9s)<\/h3>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"472\" height=\"256\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/5-jun-20-2024-03-25-23-1195-pm.webp\" class=\"wp-image-300\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/5-jun-20-2024-03-25-23-1195-pm.webp 472w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/5-jun-20-2024-03-25-23-1195-pm-300x163.webp 300w\" sizes=\"auto, (max-width: 472px) 100vw, 472px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Volume des mentions<\/h3>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"385\" height=\"74\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/1-jun-20-2024-03-01-27-0622-pm.webp\" class=\"wp-image-301\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/1-jun-20-2024-03-01-27-0622-pm.webp 385w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/1-jun-20-2024-03-01-27-0622-pm-300x58.webp 300w\" sizes=\"auto, (max-width: 385px) 100vw, 385px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Cancers les plus cit\u00e9s<\/h3>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"554\" height=\"216\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/6-jun-20-2024-03-26-47-0880-pm.webp\" class=\"wp-image-302\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/6-jun-20-2024-03-26-47-0880-pm.webp 554w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/6-jun-20-2024-03-26-47-0880-pm-300x117.webp 300w\" sizes=\"auto, (max-width: 554px) 100vw, 554px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Essais cliniques les plus mentionn\u00e9s<\/h3>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"561\" height=\"230\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/clinical-trials.webp\" class=\"wp-image-303\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/clinical-trials.webp 561w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/clinical-trials-300x123.webp 300w\" sizes=\"auto, (max-width: 561px) 100vw, 561px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">R\u00e9actions des professionnels de la sant\u00e9 au sujet de KIM-1\/CLEAR<\/h3>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"296\" height=\"193\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/2-jun-20-2024-03-20-10-8481-pm.webp\" class=\"wp-image-304\"\/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"396\" height=\"503\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/3-jun-20-2024-03-22-35-7482-pm.webp\" class=\"wp-image-305\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/3-jun-20-2024-03-22-35-7482-pm.webp 396w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/3-jun-20-2024-03-22-35-7482-pm-236x300.webp 236w\" sizes=\"auto, (max-width: 396px) 100vw, 396px\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\">Comparaison d'une ann\u00e9e sur l'autre<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Le nombre total de mentions li\u00e9es \u00e0 l'ASCO 2024 a augment\u00e9 de mani\u00e8re significative \u00e0 31% par rapport \u00e0 2023, passant de 8k mentions \u00e0 107K mentions en 2024.<\/li>\n\n\n\n<li>Le volume de mentions provenant des HCP a l\u00e9g\u00e8rement augment\u00e9 2% d'une ann\u00e9e sur l'autre, passant de 30 240 en 2023 \u00e0 30 915 en 2024.<\/li>\n\n\n\n<li>Le volume des mentions des entreprises pharmaceutiques a augment\u00e9 par rapport \u00e0 l'ann\u00e9e derni\u00e8re, passant de 835 en 2023 \u00e0 899 en 224, soit une augmentation de 8%.<\/li>\n\n\n\n<li>Le volume des mentions des organisations est en baisse, passant de 10136 en 2023 \u00e0 8328 en 2024, soit une diminution de 18%.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">mRCC synditrack : une \u00e9tude bimestrielle ax\u00e9e sur le patient et les besoins de votre march\u00e9<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"926\" height=\"472\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post.webp\" class=\"wp-image-306\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post.webp 926w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post-300x153.webp 300w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post-768x391.webp 768w\" sizes=\"auto, (max-width: 926px) 100vw, 926px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">mRCC syndicated tracker : eu5 + nouveau en 2023 : Chine<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"925\" height=\"397\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post-1.webp\" class=\"wp-image-307\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post-1.webp 925w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post-1-300x129.webp 300w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post-1-768x330.webp 768w\" sizes=\"auto, (max-width: 925px) 100vw, 925px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Carcinome uroth\u00e9lial m\u00e9tastatique (mUC) : Preuves dans le monde r\u00e9el<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"973\" height=\"446\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post-2.webp\" class=\"wp-image-308\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post-2.webp 973w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post-2-300x138.webp 300w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post-2-768x352.webp 768w\" sizes=\"auto, (max-width: 973px) 100vw, 973px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">tracker syndiqu\u00e9 de la vessie mUC : EU5 + nouveau en 2024 : US &amp; JP<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"1951\" height=\"824\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post-3.webp\" class=\"wp-image-309\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post-3.webp 1951w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post-3-300x127.webp 300w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post-3-1024x432.webp 1024w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post-3-768x324.webp 768w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2024\/06\/congress-track-post-3-1536x649.webp 1536w\" sizes=\"auto, (max-width: 1951px) 100vw, 1951px\" \/><\/figure>","protected":false},"excerpt":{"rendered":"<p>The 2024 ASCO annual meeting took place from May 31st to June 4th, 2024, in Chicago, Il, USA. This year\u2019s event was primarily an in-person event with virtual broadcasts available. As has been the case since 2019 we will be assessing the impact of the conference online: From the view of HCPs: From the view [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":7474,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"none","_seopress_titles_title":"","_seopress_titles_desc":"Explore ASCO 2024 social listening insights: HCP engagement, top cancer trials, multiple myeloma focus, and key molecular testing trends worldwide.","_seopress_robots_index":"","content-type":"","footnotes":""},"categories":[80],"tags":[],"class_list":{"0":"post-70","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-views"},"acf":[],"_links":{"self":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts\/70","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/comments?post=70"}],"version-history":[{"count":0,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts\/70\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/media\/7474"}],"wp:attachment":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/media?parent=70"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/categories?post=70"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/tags?post=70"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}